CYRIB
CYFIP-related Rac1 interactor B
Also known as: BM-009, CYRI, CYRI-B, CYRIB_HUMAN, FAM49B
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NUQ9
- Gene
- CYRIB
- Ensembl
- ENSG00000153310
- Chromosome
- 8
- Canonical length
- 324 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Enables small GTPase binding activity. Involved in several processes, including cellular response to molecule of bacterial origin; negative regulation of small GTPase mediated signal transduction; and regulation of organelle organization. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
324 residues, UniProt reviewed canonical sequence.
>Q9NUQ9|CYRIB
1 MGNLLKVLTC TDLEQGPNFF LDFENAQPTE SEKEIYNQVN VVLKDAEGIL EDLQSYRGAG
61 HEIREAIQHP ADEKLQEKAW GAVVPLVGKL KKFYEFSQRL EAALRGLLGA LTSTPYSPTQ
121 HLEREQALAK QFAEILHFTL RFDELKMTNP AIQNDFSYYR RTLSRMRINN VPAEGENEVN
181 NELANRMSLF YAEATPMLKT LSDATTKFVS ENKNLPIENT TDCLSTMASV CRVMLETPEY
241 RSRFTNEETV SFCLRVMVGV IILYDHVHPV GAFAKTSKID MKGCIKVLKD QPPNSVEGLL
301 NALRYTTKHL NDETTSKQIK SMLQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CYRIB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 187 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 187 nTPM
- lymph node: 111 nTPM
- tonsil: 98 nTPM
- appendix: 92 nTPM
- spleen: 78 nTPM
- thymus: 74 nTPM
Single-cell type
- neutrophils: 6,072 nCPM
- neutrophil progenitors: 1,953 nCPM
- microglia: 1,238 nCPM
- monocytes: 744 nCPM
- nk-cells: 705 nCPM
- cdc: 636 nCPM
Immune cell
- neutrophil: 541 nTPM
- eosinophil: 388 nTPM
- basophil: 331 nTPM
- total PBMC: 292 nTPM
- myeloid DC: 269 nTPM
- intermediate monocyte: 246 nTPM
Brain region
- white matter: 114 nTPM
- medulla oblongata: 88 nTPM
- spinal cord: 84 nTPM
- basal ganglia: 83 nTPM
- thalamus: 83 nTPM
- pons: 80 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.31
- gnomAD pLI
- 0.98
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 13% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to molecule of bacterial origin
- negative regulation of actin filament polymerization
- negative regulation of small GTPase mediated signal transduction
- positive regulation of memory T cell activation
- positive regulation of T cell activation
- positive regulation of T cell mediated cytotoxicity
- positive regulation of type II interferon production
- regulation of cell migration
- regulation of chemotaxis
- regulation of establishment of cell polarity
- regulation of mitochondrial fission
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CYRIB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CYRIB as an antibody target. Whether an autoantibody or antibody against CYRIB could matter depends on whether native CYRIB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CYRIB is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CYRIB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...